English Русский About us Services Experience Careers Contacts OCT History 2014 Data MATRIX OCT Data Management department has reached a point in its development where it is capable of functioning independently and has been spun-off into a separate company Data MATRIX with 30 specialists on staff. OCT clinical staff now number 90 employees 2013 North America Our company reached 120 employees on staff. We are a premium full-service CRO conducting clinical trials in 8 countries, including North America . 2012 IWRS IWRS system development completed. Team of 90 people operating across 6 offices. 2011 EDC Clinical trials conducted on in-house developed eDC platform launched. Pharmacovigilance services added to the portfolio. Team grows to 85. 2010 Full Service CRO OCT becomes truly full-service: first Agreement for Data Management services signed. Team grows to 75. 2009 Data Management and Statistics Data Management and Statistics department established. Team of 60 is fully operational with access to CIS and EU Regions. 2008 Offices in Belaruss and Latvia Offices in Minsk, Belarus; Riga, Latvia and Moscow are opened and team grows to 50. 2007 Offices in Ukraine and Bulgaria OCT expands to Kiev, Ukraine and Sofia, Bulgaria, with opening of local offices. Team grows to 20 people. 2006 Operations in Russia Team of 10 begins operations in Russia focusing on regulatory and monitoring services. 2005 Company foundation The company is founded by Dmitry Sharov. First contract for local project management and clinical monitoring in Russia signed. © ОСТ. Clinical Trials in Central Europe, Russia, Ukraine, Georgia, Bulgaria, Latvia, Estonia, Lithuania, Belarus, Germany, England and the US. 2005–2016 Any part of this site is protected by law and may not be copied without special agreement with OCT Sitemap Contacts Disclaimer Sign in

English Русский About us Services Experience Careers Contacts OCT Location Emerging markets such as Central and Eastern Europe have become widely accepted by the biopharmaceutical industry as ideal locations for conducting clinical trials due to their high enrollment rates, unparalleled access to untapped patient populations, experienced investigators and centralized healthcare systems. Having proved itself as a leading CRO in CEE, OCT has started operations in the US. OCT’s footprint includes the following countries: Russia Ukraine Belarus Latvia Estonia Lithuania Bulgaria Georgia USA OCT are not limited to the above listed countries and have well developed networks and connections with several leading Western European CROs. All this enables us to perform studies in any region (if required). © ОСТ. Clinical Trials in Central Europe, Russia, Ukraine, Georgia, Bulgaria, Latvia, Estonia, Lithuania, Belarus, Germany, England and the US. 2005–2016 Any part of this site is protected by law and may not be copied without special agreement with OCT